Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. (Q53752043)

19 May 2018

title

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. (English)

1 reference

19 May 2018

0 references

1 reference

1 reference

congestive heart failure

1 reference

C A Simonton

1

1 reference

19 May 2018

K Chatterjee

2

1 reference

19 May 2018

R J Cody

3

1 reference

19 May 2018

S H Kubo

4

1 reference

19 May 2018

D Leonard

5

1 reference

19 May 2018

P Daly

6

1 reference

19 May 2018

H Rutman

7

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 August 1985

1 reference

19 May 2018

Journal of the American College of Cardiology

published in

1 reference

19 May 2018

volume

6

1 reference

19 May 2018

issue

2

1 reference

19 May 2018

page(s)

453-459

1 reference

19 May 2018

The role of vasodilator therapy in heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Thermodilution cardiac output determination with a single flow-directed catheter

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(85)80185-6

7 January 2021

10.1016/S0735-1097(85)80185-6

Identifiers

DOI

1 reference

19 May 2018

1 reference

19 May 2018